Stocks and InvestingStocks and Investing
Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021

David Lebowitz Maintained (ARQT) at Buy with Decreased Target to $50 on, Jul 16th, 2021


Published on 2024-10-27 17:14:02 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Decreased Target from $52 to $50 on, Jul 16th, 2021.

David has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Uy Ear of "Mizuho" Initiated at Strong Buy and Held Target at $58 on, Wednesday, June 30th, 2021